Factors related to non-alcoholic fatty liver disease in obese children

Turkish Journal of Gastroenterology

Volumn 19, Issue 2, 2008, Pages 85-91

  Eminoǧlu, Tuba F ^a,b   Çamurdan, Orhun M ^a   Oktar, Suna Ö ^a   Bideci, Aysun ^a   Dalgiç, Buket ^a  

^a GAZI UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Childhood; Non alcoholic fatty liver disease; Obesity; Ultrasonography

Indexed keywords

ALANINE AMINOTRANSFERASE; INSULIN; LEPTIN; VERY LOW DENSITY LIPOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NONALCOHOLIC FATTY LIVER; OBESITY;

ALANINE TRANSAMINASE; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CAUSALITY; CHILD; COMORBIDITY; FATTY LIVER; FEMALE; HUMANS; INSULIN; LEPTIN; LIPOPROTEINS, VLDL; MALE; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 45849152561     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relation to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-9.
2. Day CP, Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002; 17: 377-84.
3. Stephen CH, Tri HL, Stacey MA. Non alcoholic steatohepatitis. In: Textbook. Schiff's diseases of liver. 9th ed. Philadelphia, PA: Lippincott William&Wilkins, 2002; 1261-89.
4. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
5. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127: 700-4.
6. Kerkar N, Aw MM, Vergani D, et al. Non-alcoholic fatty liver disease in children. J Paediatr Gastroenterol Nutr 2002; 34: 441.
7. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-6.
8. Lee RG. Non-alcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20: 594-8.
9. Ludwig J, Viggiano TR, McGill DB, et al. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
10. Pinto HC, Baptista A, Camilo ME, et al. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996; 41: 172-9.
11. Powell EE, Cookesley EGE, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
12. Marchesini G, Brizi M, Bianchi G, et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358: 893-4.
13. MacDonald GA, Bridle KR, Ward PJ, et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominantly in acinar zone 3. J Gastroenterol Hepatol 2001; 16: 599-606.
14. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
15. Kaplan LM. Leptin, obesity and liver disease. Gastroenterology 1998; 115: 997-1001.
16. Uygun A, Kadayifci A, Ye.ilova Z, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 3584-9.
17. Cinaz P, Çamurdan MO, Maral I, et al. 6-16 yaş arasi çocuklarda VKİ deǧerlerinin daǧilimi. VIII. Ulusal Pediatrik Endokrinoloji Kongre Özet Kitabi, Erzurum: 2003; 230.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
19. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997; 86: 238-41.
20. Vajro P, Fontanella A, Perna C, et al. Persistent hypertransaminasemia resolving after weight reduction in obese children. J Pediatr 1994; 25: 239-41.
21. Bergomi A, Lughetti L, Corciulo N, et al. Italian multicenter study on liver damage in pediatric obesity. Int J Obes Relat Metab Disord 1998; 22: 22.
22. Miller GD, Frost R, Olive J. Relation of plasma leptin concentrations to sex, body fat, dietary intake, and peak oxygen uptake in young adult women and men. Nutrition 2001; 17: 105-11.
23. Cusin I, Sainsbury A, Doyle P, et al. The ob gene and insulin, a relationship leading to clues to the understanding of obesity. Diabetes 1995; 44: 1467-70.
24. Frederich RC, Hamann A, Anderson S, et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-4.
25. Chalasani N, Crabb DW, Cummings OW, et al. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 2003; 98: 2771-6.
26. Nakao K, Nakata K, Ohtsubo N, et al. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol 2002; 97: 1796-801.
27. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913-7.
28. Ikejima K, Honda H, Yoshikawa M, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001; 34: 288-97.
29. Serin E, Ozer B, Gumurdulu Y, et al. Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver. J Gastroenterol 2003; 38: 471-6.
30. Angulo P, Alba LM, Petrovic LM, et al. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 2004; 41: 943-9.
31. Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002; 87: 2395.
32. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003; 107: 1448-53.
33. Radetti G, Kleon W, Stuefer J, et al. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr 2006; 95: 833-7.
34. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-63.
35. Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32: 3-10.
36. Mayes PA. Lipid transport and storage. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's biochemistry. 24th ed. Norwalk, CT: Appleton & Lange, 1996; 254-76.
37. Mensenkamp AR, Havekes LM, Romijn JA, Kuipers F. Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol 2001; 35: 816-22.
38. Charlton M, Sreekumar R, Rasmussen D, et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
39. Koruk M, Savas MC, Yilmaz O, et al. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2003; 37: 177-82.